🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 22 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/10/2011 7,20 7,20 6,90 7,20 +0,84% 4,17% 11.533
21/10/2011 7,38 7,44 7,14 7,14 -1,65% 4,07% 45.883
20/10/2011 7,56 7,62 7,26 7,26 -1,63% 4,76% 9.650
19/10/2011 7,26 7,74 7,26 7,38 +1,65% 6,61% 11.633
18/10/2011 7,20 7,50 7,20 7,26 -0,82% 4,17% 5.500
17/10/2011 7,32 7,32 7,08 7,32 -0,81% 3,28% 5.417
14/10/2011 7,02 7,62 7,02 7,38 +4,24% 8,55% 10.467
13/10/2011 7,80 8,04 7,08 7,08 -3,28% 12,31% 38.817
12/10/2011 6,84 7,32 6,78 7,32 +7,02% 7,89% 17.767
11/10/2011 6,48 6,84 6,48 6,84 +2,70% 5,56% 61.717
10/10/2011 6,60 6,78 6,42 6,66 +0,00% 5,45% 31.583
07/10/2011 6,78 6,90 6,42 6,66 +0,91% 7,08% 20.867
06/10/2011 6,60 6,78 6,60 6,60 -1,79% 2,73% 5.250
05/10/2011 6,84 6,90 6,42 6,72 -1,75% 7,02% 197.750
04/10/2011 6,72 6,96 6,48 6,84 +0,00% 7,14% 59.367
03/10/2011 6,96 7,02 6,60 6,84 -2,56% 6,03% 16.767
30/09/2011 6,60 7,02 6,36 7,02 +6,36% 10,00% 28.783
29/09/2011 7,02 7,02 6,54 6,60 -5,17% 6,84% 14.233
28/09/2011 7,26 7,26 6,66 6,96 -4,92% 8,26% 22.700
27/09/2011 6,96 7,74 6,90 7,32 +10,91% 12,07% 87.933
26/09/2011 7,02 7,02 6,60 6,60 -6,78% 5,98% 6.983
23/09/2011 6,72 7,08 6,60 7,08 +7,27% 7,14% 10.400
22/09/2011 6,90 7,02 6,60 6,60 -7,56% 6,09% 35.483
21/09/2011 7,50 7,74 7,14 7,14 -3,25% 8,00% 14.633
20/09/2011 7,80 7,80 7,26 7,38 -3,91% 6,92% 12.950
19/09/2011 7,86 8,04 7,56 7,68 -4,48% 6,11% 13.483
16/09/2011 8,04 8,16 7,44 8,04 -2,90% 8,96% 76.567
15/09/2011 7,32 8,70 7,32 8,28 +15,00% 18,85% 152.817
14/09/2011 6,90 7,32 6,60 7,20 +4,35% 10,43% 33.967
13/09/2011 6,72 6,96 6,60 6,90 +3,60% 5,36% 8.900